These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 18492463)
1. Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities. Wong ET; Brem S J Natl Compr Canc Netw; 2008 May; 6(5):515-22. PubMed ID: 18492463 [TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic therapies for glioblastoma. Arrillaga-Romany I; Norden AD CNS Oncol; 2014; 3(5):349-58. PubMed ID: 25363007 [TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas. Argyriou AA; Giannopoulou E; Kalofonos HP Oncology; 2009; 77(1):1-11. PubMed ID: 19439998 [TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in glioblastoma multiforme: navigating the maze. Linkous AG; Yazlovitskaya EM Anticancer Agents Med Chem; 2011 Oct; 11(8):712-8. PubMed ID: 21707499 [TBL] [Abstract][Full Text] [Related]
5. The role of avastin in the management of recurrent glioblastoma. Sweet JA; Feinberg ML; Sherman JH Neurosurg Clin N Am; 2012 Apr; 23(2):331-41, x. PubMed ID: 22440876 [TBL] [Abstract][Full Text] [Related]
6. New Directions in Anti-Angiogenic Therapy for Glioblastoma. Wang N; Jain RK; Batchelor TT Neurotherapeutics; 2017 Apr; 14(2):321-332. PubMed ID: 28083806 [TBL] [Abstract][Full Text] [Related]
7. Anti-Angiogenics: Their Role in the Treatment of Glioblastoma. Winkler F; Osswald M; Wick W Oncol Res Treat; 2018; 41(4):181-186. PubMed ID: 29562225 [TBL] [Abstract][Full Text] [Related]
8. [Angiogenesis and anti-angiogenic strategies for glioblastoma]. de Boüard S; Guillamo JS Bull Cancer; 2005 Apr; 92(4):360-72. PubMed ID: 15888393 [TBL] [Abstract][Full Text] [Related]
10. Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation. Takano S Brain Tumor Pathol; 2012 Apr; 29(2):73-86. PubMed ID: 22218709 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic synergy of TNP-470 and ionizing radiation: effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts. Lund EL; Bastholm L; Kristjansen PE Clin Cancer Res; 2000 Mar; 6(3):971-8. PubMed ID: 10741723 [TBL] [Abstract][Full Text] [Related]
13. Multiprong control of glioblastoma multiforme invasiveness: blockade of pro-inflammatory signaling, anti-angiogenesis, and homeostasis restoration. Bazan NG; Reid MM; Flores VAC; Gallo JE; Lewis W; Belayev L Cancer Metastasis Rev; 2021 Sep; 40(3):643-647. PubMed ID: 34519960 [TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic therapy for glioblastoma: the challenge of translating response rate into efficacy. de Groot J; Reardon DA; Batchelor TT Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714460 [TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme. Gossmann A; Helbich TH; Kuriyama N; Ostrowitzki S; Roberts TP; Shames DM; van Bruggen N; Wendland MF; Israel MA; Brasch RC J Magn Reson Imaging; 2002 Mar; 15(3):233-40. PubMed ID: 11891967 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis. Pishko GL; Muldoon LL; Pagel MA; Schwartz DL; Neuwelt EA Fluids Barriers CNS; 2015 Feb; 12():5. PubMed ID: 25879723 [TBL] [Abstract][Full Text] [Related]
20. Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro. Sun C; Yu Y; Wang L; Wu B; Xia L; Feng F; Ling Z; Wang S J Exp Clin Cancer Res; 2016 Feb; 35():32. PubMed ID: 26872471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]